SOMATOSTATIN IS INCREASED IN THE BASAL GANGLIA IN HUNTINGTON DISEASE

被引:166
作者
ARONIN, N
COOPER, PE
LORENZ, LJ
BIRD, ED
SAGAR, SM
LEEMAN, SE
MARTIN, JB
机构
[1] MASSACHUSETTS GEN HOSP,DEPT NEUROL,BOSTON,MA 02114
[2] MASSACHUSETTS GEN HOSP,NEUROENDOCRINE LAB,BOSTON,MA 02114
[3] HARVARD UNIV,SCH MED,BOSTON,MA 02115
[4] UNIV MASSACHUSETTS,SCH MED,DEPT PHYSIOL,WORCESTER,MA 01605
关键词
D O I
10.1002/ana.410130508
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:519 / 526
页数:8
相关论文
共 55 条
[1]  
ARNOLD MA, 1982, J NEUROSCI, V2, P674
[2]  
BEAL MF, 1982, 12TH ANN M SOC NEUR, P507
[3]   CHEMICAL PATHOLOGY OF HUNTINGTONS-DISEASE [J].
BIRD, ED .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1980, 20 :533-551
[4]   HUNTINGTONS-CHOREA - POSTMORTEM MEASUREMENT OF GLUTAMIC-ACID DECARBOXYLASE, CHOLINE-ACETYLTRANSFERASE AND DOPAMINE IN BASAL GANGLIA [J].
BIRD, ED ;
IVERSEN, LL .
BRAIN, 1974, 97 (SEP) :457-472
[5]   HYPOTHALAMIC POLYPEPTIDE THAT INHIBITS SECRETION OF IMMUNOREACTIVE PITUITARY GROWTH-HORMONE [J].
BRAZEAU, P ;
VALE, W ;
BURGUS, R ;
LING, N ;
BUTCHER, M ;
RIVIER, J ;
GUILLEMIN, R .
SCIENCE, 1973, 179 (4068) :77-79
[6]  
BRUYN GW, 1979, HUNTINGTONS DIS, P83
[7]   REDUCTION IN BASAL GANGLIA AND SUBSTANTIA NIGRA SUBSTANCE-P LEVELS IN HUNTINGTONS-DISEASE [J].
BUCK, SH ;
BURKS, TF ;
BROWN, MR ;
YAMAMURA, HI .
BRAIN RESEARCH, 1981, 209 (02) :464-469
[8]  
CHESSELET MF, J NEUROSCI
[9]  
COHN L, 1975, BRAIN RES, V96, P138
[10]  
COOPER PE, 1981, NEUROLOGY, V31, P64